News – Page 733 – Endpoints News

Gilead and Novo Nordisk expand NASH deal with new study; Pfizer out-licenses ADCs to a biotech startup

5 years ago

Living in its post-Shire world, Takeda continues aggressive licensing push in $2.3B deal with Anima

5 years ago

Top biotech investor Peter Kolchinsky tees up a new SPAC — 3 days after a $300M raise for radiopharmaceuticals play

5 years ago

Pfizer lays down its hand on Chinese biosims, offloading its 3-year-old plant to WuXi Biologics as competition grows

5 years ago

Roger Perlmutter’s latest ‘retirement’ gig opens a door to the bustling China biotech scene

5 years ago

CAR-M era begins as Carisma doses first patient

5 years ago

Covid-19 roundup: Facing supply delay, UK fires shot at Europe after EU threatens to ban AstraZeneca vaccine exports

5 years ago

Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take

5 years ago

Got a revolutionary healthcare company? Bob Nelsen, Jeff Leiden’s SPAC has $500M to take it public

5 years ago

Little Apellis is arming itself for a David and Goliath battle over a blockbuster drug franchise

5 years ago

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

5 years ago

Lack of early efficacy for Translate Bio's mRNA-based cystic fibrosis drug raises some big questions

5 years ago

Denied top job, Mike Nally exits chief marketing job at Merck as the big C-suite shakeup continues

5 years ago

New Purdue bankruptcy plan roundly criticized as Sacklers offer $4B+; Sana seals pact with Fujifilm for iPSC-derived ...

5 years ago

Dean Li invites another under-the-radar biotech to Merck's dealmaking table as Amathus signs neurodegeneration pact

5 years ago

Europe mulls halting Covid-19 vaccine exports to some countries

5 years ago

A departing CMO pens a sad farewell as he heads back to the UK biopharma scene

5 years ago

Court win for Eli Lilly halts HHS’s drug discount rule

5 years ago

Hunting unicorn status, the co-inventors of the Oxford-AstraZeneca vaccine raise a monster B round

5 years ago

After a roller coaster ride, Sage COO strikes out on his own to chart a new biotech path

5 years ago

Covid-19 roundup: Alnylam, Vir quietly deprioritize Covid-19 drug; Data suggest AstraZeneca's vaccine is only 10.4% ...

5 years ago

Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split

5 years ago

Montreal AI startup with a touted advisor licenses its 'few-shot' platform to Repare for synthetic lethality ...

5 years ago

Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders

5 years ago

First page Previous page 730 731 732733734 735 736 Next page Last page